Skip to main content
HTG, Qiagen unit enter into statement of work
6/15/2017

A statement of work has been signed by HTG Molecular Diagnostics and a Qiagen subsidiary to perform initial-phase development work on a sequencing-based companion diagnostic assay. Net profits from the initial phase will be shared by both companies.

Full Story: